Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$980K Buy
7,577
+95
+1% +$11.1K 0.44% 41
2026
Q1
$906K Hold
7,482
0.51% 31
2025
Q4
$794K Buy
7,482
+913
+14% +$85.7K 0.43% 37
2025
Q3
$557K Hold
6,569
0.3% 56
2025
Q2
$525K Sell
6,569
-904
-12% -$71.9K 0.32% 55
2025
Q1
$677K Buy
7,473
+1,371
+22% +$128K 0.44% 36
2024
Q4
$612K Sell
6,102
-885
-13% -$91.2K 0.35% 42
2024
Q3
$799K Sell
6,987
-560
-7% -$66.5K 0.51% 29
2024
Q2
$940K Buy
+7,547
New +$972K 0.56% 26

Other funds holding MRK

Cromwell Holdings's MRK Position: Q2 2026 in Review

Cromwell Holdings increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $11.1K and bringing the position to 7,577 shares worth $980K. The position accounts for 0.44% of the portfolio, ranked #41.

Cromwell Holdings first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cromwell Holdings held 7,577 shares of Merck worth $980K as of Q2 2026.
  • Cromwell Holdings bought 95 Merck shares in Q2 2026, an estimated $11.1K.
  • Merck made up 0.44% of Cromwell Holdings's portfolio in Q2 2026, its #41 holding.
  • Cromwell Holdings first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.